Biostatistics Shared Resources Core
生物统计学共享资源核心
基本信息
- 批准号:10116300
- 负责人:
- 金额:$ 83.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Acute Lymphocytic LeukemiaAdherenceAffectAnusBasic ScienceBig DataBiologicalBiometryBiostatistics Shared ResourceBloodBone DensityBone Mineral ContentsCancer Center Support GrantCancer ControlChildChildhood Acute Lymphocytic LeukemiaClinical InvestigatorClinical OncologyClinical ResearchClinical TrialsClinical assessmentsCollaborationsComplexComputer SystemsComputer softwareConsultConsultationsDataData AnalysesDepartment chairDevelopmentDiagnosisDisease MarkerDoseDrug KineticsEducational StatusEducational workshopEnrollmentEnsureFacultyFollow-Up StudiesFrequenciesFundingGenesGeneticGenetic MarkersGenomicsGoalsGrowthImmunotherapyInformation ServicesInfrastructureJournalsLaboratoriesLate EffectsLife Cycle StagesMalignant Childhood NeoplasmMalignant NeoplasmsMeasuresMethodologyMethodsMissionMolecularMotivationMutationNatureNeuropathyNewly DiagnosedOncologyOutcomePaperPatientsPhysical FunctionPhysical activityPhysical therapyPopulationProcessPublicationsQuality of lifeRadiation exposureRadiology SpecialtyRandomizedRemission InductionResearchResearch DesignResearch PersonnelResearch Project GrantsResidual NeoplasmResource SharingRiskSaint Jude Children&aposs Research HospitalScientific Advances and AccomplishmentsSeveritiesSurvivorsSystemTherapeuticTherapeutic InterventionTimeTranslatingUnited StatesUpdateVincristineWorkanticancer researchbasecancer clinical trialcohortdesigndisorder subtypeelectronic data capture systemexercise intensityexperienceimprovedindexinglecturesleukemia treatmentmedulloblastomamembermulti-site trialneurotoxicitypersonalized medicineprecision medicineprogramsrecruitrelapse risksoundsurvivorshiptranslational scientisttreatment as usual
项目摘要
PROJECT SUMMARY/ABSTRACT— Biostatistics Shared Resource
The Biostatistics Shared Resource (BSR) is a SJCCC managed shared resource with the overarching mission
of impacting pediatric cancer through biostatistics collaboration and consulting, and through comprehensive,
effective, and timely biostatistical support to Center members. BSR has a highly experienced and interactive
team of biostatisticians who work collaboratively with researchers who are conducting leading edge basic
science, clinical research, and population and survivorship research from the 5 SJCCC Programs. This is
evidenced by the high level of collaborative publications and key scientific contributions in high-impact journals
such as Journal of Clinical Oncology (n=31), Cancer (n=31), Nature Genetics (n=9), and Lancet Oncology (n=4).
In addition, BSR biostatisticians are well integrated into the clinical trial teams providing statistical support
throughout the life cycle of the research project from concept development through publication. During the last
funding period, 85% of all SJCCC publications used the BSR and 77% (n=358/468) of all collaborative
publications with a biostatistician as a co-author were associated with SJCCC programs. These included papers
from all 5 of the programs: CCSP (n = 103), CBP (n = 1), DBSTP (n = 66), NBTP (n = 83), and HMP (n = 105).
A total of 125 St. Jude investigators and their staff used the BSR during the index year (FY2017). Of those, 71
(57%) were SJCCC members. The BSR faculty also offer workshops, office consultations, lectures, seminars,
Grand Rounds, and courses on study design, analysis methods, and software implementation to fellows,
research staff, and faculty. The BSR is led by Dr. Deo Kumar Srivastava who has more than 23 years'
experience in the statistical design and analysis of cancer research and cancer clinical trials. He is supported by
9 faculty biostatisticians and 13 master's-level trained staff, ensuring that BSR support is available to
investigators throughout all 5 programs. During our most recent funding period, BSR has witnessed growth
driven by the strengthening of the scientific programs, research in genomic characterization of pediatric cancers,
and focus on complex precision medicine SJCCC investigator-initiated multisite trials. Goals for the next funding
period include continuing to provide state-of-the-art statistical support to all SJCCC investigators including new
investigators, and targeted recruitment of biostatisticians to strengthen expertise in personalized medicine,
immunotherapy, and in expansion of high-throughput big data. Lastly, BSR will closely partner with the
Information Services department in the implementation of the new software provided by the Clinical Trials
Management System.
项目摘要/摘要 — 生物统计学共享资源
生物统计共享资源 (BSR) 是 SJCCC 管理的共享资源,其首要任务是
通过生物统计学合作和咨询,以及通过全面、
为中心成员提供有效、及时的生物统计支持。 BSR 拥有经验丰富、互动性强的团队
生物统计学家团队与正在进行前沿基础研究的研究人员合作
5 个 SJCCC 项目的科学、临床研究以及人口和生存研究。这是
高影响力期刊上的高水平合作出版物和关键科学贡献证明了这一点
例如《临床肿瘤学杂志》(n=31)、《癌症》(n=31)、《自然遗传学》(n=9) 和《柳叶刀肿瘤学》(n=4)。
此外,BSR生物统计学家很好地融入了临床试验团队,提供统计支持
贯穿研究项目从概念开发到出版的整个生命周期。最后期间
资助期内,85% 的 SJCCC 出版物使用了 BSR,77% (n=358/468) 的所有协作出版物使用了 BSR
由生物统计学家作为合著者的出版物与 SJCCC 项目相关。这些包括论文
来自所有 5 个计划:CCSP (n = 103)、CBP (n = 1)、DBSTP (n = 66)、NBTP (n = 83) 和 HMP (n = 105)。
在索引年(2017 财年),共有 125 名 St. Jude 调查员及其工作人员使用了 BSR。其中,71
(57%) 是 SJCCC 会员。 BSR 教师还提供讲习班、办公室咨询、讲座、研讨会、
大查房,以及为研究员提供的研究设计、分析方法和软件实施课程,
研究人员和教师。 BSR 由 Deo Kumar Srivastava 博士领导,他拥有超过 23 年的丰富经验
在癌症研究和癌症临床试验的统计设计和分析方面拥有丰富的经验。他的支持者是
9 名生物统计学家和 13 名经过硕士培训的工作人员,确保 BSR 支持
所有 5 个项目的调查员。在我们最近的融资期间,BSR 见证了增长
在加强科学计划、儿科癌症基因组特征研究的推动下,
并专注于复杂的精准医学 SJCCC 研究者发起的多中心试验。下一次融资的目标
期间包括继续向所有 SJCCC 调查员提供最先进的统计支持,包括新的调查员
研究人员,并有针对性地招募生物统计学家以加强个性化医疗的专业知识,
免疫疗法,以及高通量大数据的扩展。最后,BSR 将与
信息服务部门实施临床试验提供的新软件
管理系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MOTOMI MORI其他文献
MOTOMI MORI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MOTOMI MORI', 18)}}的其他基金
IMPLICATIONS OF HLA POLYMORPHISM FOR DONOR RECRUITMENT
HLA 多态性对捐赠者招募的影响
- 批准号:
2234923 - 财政年份:1996
- 资助金额:
$ 83.52万 - 项目类别:
IMPLICATIONS OF HLA POLYMORPHISM FOR DONOR RECRUITMENT
HLA 多态性对捐赠者招募的影响
- 批准号:
2901242 - 财政年份:1996
- 资助金额:
$ 83.52万 - 项目类别:
IMPLICATIONS OF HLA POLYMORPHISM FOR DONOR RECRUITMENT
HLA 多态性对捐赠者招募的影响
- 批准号:
2685483 - 财政年份:1996
- 资助金额:
$ 83.52万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 83.52万 - 项目类别:
Fellowship Programs